AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in AEON Biopharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −4 vs. Q1 2023
- Shares held
- 1.32M
- −604.7K (−31.4%) vs. Q1 2023
- Total value
- $12.0M
- −$7.57M (−38.7%) vs. Q1 2023
- New holders
- 3
- 2 more added
- Sold out
- 7
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 236,236 | $2.49M | 0.08% | 00.0% | Unchanged |
| Fir Tree Capital Management LP | 200,000 | $2.00M | 0.20% | 00.0% | Unchanged |
| Periscope Capital Inc. | 150,000 | $1.58M | 0.12% | 00.0% | Unchanged |
| Empyrean Capital Partners, LP | 200,000 | $1.42M | 0.07% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 200,000 | $1.42M | 0.03% | 00.0% | Unchanged |
| Sandia Investment Management LP | 117,135 | $1.17M | 0.37% | −13,312−10.2% | Reduced |
| Glazer Capital, LLC | 59,166 | $613.0K | 0.04% | −163,378−73.4% | Reduced |
| Berkley W R Corp | 49,887 | $525.8K | 0.03% | 00.0% | Unchanged |
| Flow Traders U.S. LLC | 19,044 | $135.0K | 0.01% | −1,928−9.2% | Reduced |
| Walleye Capital LLC | 18,240 | $129.1K | 0.00% | +2,240+14.0% | Added |
| Clear Street LLC | 18,000 | $127.4K | 0.00% | +11,206+164.9% | Added |
| Geode Capital Management, LLC | 14,763 | $106.8K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 15,000 | $106.2K | 0.02% | −83,167−84.7% | Reduced |
| Walleye Trading LLC | 10,260 | $72.6K | 0.00% | +10,260 | New |
| Cowen and Company, LLC | 10,000 | $70.8K | 0.01% | +10,000 | New |
| Ancora Advisors, LLC | 5,800 | $41.1K | 0.00% | +5,800 | New |
| Barclays PLC | 194 | $1.37K | 0.00% | 00.0% | Unchanged |
| Castle Creek Arbitrage, LLC | 0 | $0 | 0.00% | −105,807−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −70,747−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −54,108−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −30,087−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −11,831−100.0% | Sold out |
| Graham Capital Wealth Management, LLC | 0 | $0 | 0.00% | −9,820−100.0% | Sold out |